KAREN MIELE: Open Payments
NPI 1053009688 · ROWLETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 17 payments from 6 companies in 2025. Trend: 2023 $310 · 2024 $652 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 7 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $68 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $64 |
| ABBVIE INC. | 2 | $39 |
| Boston Scientific Corporation | 2 | $38 |
| PFIZER INC. | 1 | $17 |
Products named: XTAMPZA, RELISTOR, JOURNAVX, Intracept, UBRELVY, NURTEC ODT, QULIPTA.
Industry payments across TX — which companies pay providers there.
